Loading…

Impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the meningococcal carriage

Highlights • We conducted a meningococcal carriage study among children aged 1–7 years old. • We evaluated the impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the pharyngeal meningococcal carriage. • MenBvac reduces meningococcal carriage and may hence confer herd immunity. • The nove...

Full description

Saved in:
Bibliographic Details
Published in:Vaccine 2013-09, Vol.31 (40), p.4416-4420
Main Authors: Delbos, Valérie, Lemée, Ludovic, Bénichou, Jacques, Berthelot, Gilles, Deghmane, Ala-Eddine, Leroy, Jean-Philippe, Houivet, Estelle, Hong, Eva, Taha, Muhamed-Kheir, Caron, François
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • We conducted a meningococcal carriage study among children aged 1–7 years old. • We evaluated the impact of MenBvac, an outer membrane vesicle (OMV) vaccine, on the pharyngeal meningococcal carriage. • MenBvac reduces meningococcal carriage and may hence confer herd immunity. • The novel meningococcal B vaccine that includes an OMV component may have an impact on carriage.
ISSN:0264-410X
1873-2518
0264-410X
DOI:10.1016/j.vaccine.2013.06.080